BUSINESS COMBINATION - Narrative (Details) $ / shares in Units, $ in Thousands		3 Months Ended		9 Months Ended
	Sep. 16, 2024 USD ($) contingentValueRight $ / shares	Sep. 30, 2024 USD ($)	Sep. 30, 2023 USD ($)	Sep. 30, 2024 USD ($)	Sep. 30, 2023 USD ($)
Business Acquisition [Line Items]
Selling, general and administrative expenses		$ 79,075	$ 42,007	$ 179,917	$ 117,235
Research and development expense		10,128	$ 11,121	27,935	$ 24,419
Business combination, pro forma information, revenue of acquiree since acquisition date, actual				3,900
Business combination, pro forma information, earnings or loss of acquiree since acquisition date, actual				(8,100)
Alimera Sciences, Inc
Business Acquisition [Line Items]
Common Stock, par value (in dollars per share) | $ / shares	$ 0.01
Cash consideration per share (in dollars per share) | $ / shares	$ 5.50
Business combination, number of contingent value rights to be received | contingentValueRight	1
Business combination, milestone payment multiplier	0.25
Repayment of Alimera Debt	$ 78,540
Payment of Alimera transaction costs	20,172
Payment of settlement of acquiree's equity awards	19,300
Cash paid at closing for settlement of equity awards	1,300
Cash settlement for pre-acquisition equity awards	9,535
Selling, general and administrative expenses		8,800		8,800
Research and development expense		1,000		1,000
Fair value of CVRs	8,322
Business combination, contingent value rights	8,700
Payment of Alimera transaction costs				12,200
Alimera Sciences, Inc | Contingent Value Right
Business Acquisition [Line Items]
Selling, general and administrative expenses		$ 400		$ 400
Alimera Sciences, Inc | 2026 Milestone Revenue Payment
Business Acquisition [Line Items]
Revenues	140,000
Business combination, divisible revenue	10,000
Alimera Sciences, Inc | 2026 Milestone Revenue Payment | Maximum
Business Acquisition [Line Items]
Revenues	151,000
Alimera Sciences, Inc | 2027 Milestone Revenue Payment
Business Acquisition [Line Items]
Revenues	160,000
Business combination, divisible revenue	15,000
Alimera Sciences, Inc | 2027 Milestone Revenue Payment | Maximum
Business Acquisition [Line Items]
Revenues	$ 176,000